BioSpace News Archive

Bedfont Scientific Release: Local Family Business Needs Your Vote to Represent the UK in the European Business Awards

Bedfont Scientific, based in Maidstone, needs the public to vote for them to become a European Public Winner and represent the UK in the European Business Awards.

February 15, 2018

·

2 min read

BIOTECanada Welcomes Federal Government’s $950 Million Superclusters Announcement

BIOTECanada, the national industry association representing biotechnology companies attended and congratulates the Minister of Innovation, Science and Economic Development and the organizations leading the successful superclusters identified in today’s announcement.

February 15, 2018

·

2 min read

Smith & Nephew: RCT Demonstrates A 71% Reduction In The Onset Of Sacral Pressure Ulcers When Adding ALLEVYN◊ LIFE To Standard Preventative Protocol

Published in the International Wound Journal, the RCT charts the experience of 359 fragile hip fracture patients aged 65 or over.

February 15, 2018

·

6 min read

Business

Kindred Biosciences to Announce Fourth Quarter and Year-End 2017 Financial Results

The Company will host a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time that day.

February 15, 2018

·

1 min read

Theravance Biopharma Highlights Submission of Landmark IMPACT Data to EMA to Support Expanded Label for Trelegy Ellipta

If this latest submission is approved, the labeled indication for Trelegy Ellipta would include a wider population of patients with COPD who are at risk of an exacerbation and require triple therapy.

February 15, 2018

·

7 min read

Prometic Granted Orphan Drug Designation by FDA for Inter-Alpha-Inhibitor-Proteins for Treatment of Necrotizing Enterocolitis (NEC)

IaIp are endogenous proteins that control excessive inflammatory responses to toxins, infectious organisms, and tissue and organ damage.

February 15, 2018

·

6 min read

Policy

Knight Therapeutics and SIFI S.p.A. Announce Filing of New Drug Submission for NETILDEX in Canada

Knight Therapeutics and SIFI S.p.A. today announced that Knight’s New Drug Submission (NDS) for NETILDEX has been accepted for review by Health Canada.

February 15, 2018

·

3 min read

Pharm Country

Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance

New test fulfills promise of liquid biopsies to cost effectively monitor patients.

February 15, 2018

·

6 min read